Ferdinand Groenewald - 18 Aug 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Reporting relationship: Vice President of Finance
Issuer ticker: TCRT
Reported as of: 18 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Aug 2025, 19:54:48 UTC
Prior SEC filing: 02 Jun 2025
Next SEC filing: 21 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Ferdinand Groenewald

Key filing fact

Ferdinand Groenewald filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 20 Aug 2025.

Key facts

This page summarizes Ferdinand Groenewald's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Aug 2025, 19:54.

Change

Previous filing in this sequence was filed on 02 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001734018 Primary reporting owner

Groenewald Ferdinand

Relationship: Vice President of Finance
Address: C/O ALAUNOS THERAPEUTICS, INC., 501 E. LAS OLAS BLVD., SUITE 300, FORT LAUDERDALE
Signature: /s/ Ferdinand Groenewald
Signature date: 20 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TCRT transaction

Common Stock

Award

Transaction value: $0
Shares: +10,775
Change %
Price: $0.000000
Shares after: 10,775
Date: 18 Aug 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TCRT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +4,000
Change %
Price: $0.000000
Shares after: 4,000
Date: 18 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,000
Exercise price: $2.32
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date.